Filing Flows

Filing Flows › Kewaunee Scientific (KEQU) › Q2 FY26

Kewaunee Scientific (KEQU) Q2 FY26 earnings results (second quarter fiscal 2026)

10-Q filed Dec 12, 2025

Kewaunee Scientific (KEQU) reported revenue of $70.1M for the second quarter fiscal 2026 (Q2 FY26), +47% from a year earlier and -1% from the quarter before. Operating margin was 5.9%, net earnings $2.4M (3.5% of revenue).

Revenue$70.1M
Year over year+47%
Quarter over quarter-1%
Operating margin5.9%
Net earnings$2.4M

Kewaunee Scientific, Q2 FY26: revenue $70.1M (+47% year over year), operating margin 5.9%, net earnings $2.4M, operating cash flow −$4.3M. The chart follows the revenue to costs, profit and cash.

Q2 FY26AmountQ/QY/Y
Revenue$70.1M-1%+47%
Gross profit$19.7M-6%+41%
Operating profit$4.1M-15%-7%
Net earnings$2.4M-21%-19%
Operating cash flow−$4.3M-174%—

What changed

Revenue was $70.1M in Q2 FY26, up 47% year over year and down 1% from the previous quarter.

Gross margin was 28.1%, down 1.1 points from a year earlier. Operating profit was $4.1M, a 5.9% margin (down 3.4 points year over year). Operating profit fell $327K even though revenue rose $22.3M versus a year earlier, so costs grew faster than sales. Operating expenses grew 64% against revenue growth of 47%. Net earnings were $2.4M, down 19% year over year. The effective tax rate was 26.5%.

Operating cash flow was −$4.3M. Non-cash charges added back $1.6M of depreciation and $561K of share-based compensation. Working capital and other items used $8.9M. Capital expenditures of $1.6M exceeded it, leaving free cash flow of −$5.8M.

Questions

What was Kewaunee Scientific's revenue in the second quarter fiscal 2026?

Kewaunee Scientific (KEQU) reported revenue of $70.1M for the second quarter fiscal 2026 (Q2 FY26), +47% from a year earlier and -1% from the quarter before.

Was Kewaunee Scientific profitable in the second quarter fiscal 2026?

Operating profit was $4.1M (5.9% of revenue) and net earnings $2.4M.

Open the interactive Sankey →

Source: Kewaunee Scientific 10-Q on SEC EDGAR.